Checkmate Pharmaceuticals, Inc.: retained_earnings
| Value | {"amount": -140071000, "concept": "us-gaap:RetainedEarningsAccumulatedDeficit", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | Checkmate Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/19178a5d-04cb-4f16-bc53-0fc3fc64b33f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-21-098414 · Open the official SEC filing →Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001651431/retained-earnings/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/19178a5d-04cb-4f16-bc53-0fc3fc64b33f
History
- no predecessors — first report